Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2007 Feb 22;1769(4):209–219. doi: 10.1016/j.bbaexp.2007.02.002

Fig. 3.

Fig. 3

FLJ11259 family expression profiles in normal and tumor samples. (A) RT-PCR expression analysis of family members in normal cDNA samples from the Human II multiple tissue cDNA (MTC) panel (BD Bioscience). (B) Expression analysis of family members in tumor cDNA samples from the Human tumor MTC panel (BD Bioscience). (C) FLJ11259 is expressed in clinical germ cell tumor samples (GCT#1, 2 and 3). For comparison untreated and cisplatin treated (2 μM for 6 hours with a 24 hour recovery) NT2/D1 cells are shown. FLJ11259 primers are located in a region that does not distinguish between potential splice variants. GAPDH and actin primers were used for normalization. Data is representative of two independent experiments.